Your browser doesn't support javascript.
loading
Efficiency and cytotoxicity analysis of cationic lipids-mediated gene transfection into AGS gastric cancer cells.
Gharaati-Far, Nasrin; Tohidkia, Mohammad Reza; Dehnad, Alireza; Omidi, Yadollah.
Afiliación
  • Gharaati-Far N; a Research Center for Pharmaceutical Nanotechnology , Tabriz University of Medical Sciences , Tabriz , Iran.
  • Tohidkia MR; b Department of Biology, Faculty of Basic Sciences , Rab-Rashid Higher Education institute , Tabriz , Iran.
  • Dehnad A; a Research Center for Pharmaceutical Nanotechnology , Tabriz University of Medical Sciences , Tabriz , Iran.
  • Omidi Y; b Department of Biology, Faculty of Basic Sciences , Rab-Rashid Higher Education institute , Tabriz , Iran.
Artif Cells Nanomed Biotechnol ; 46(5): 1001-1008, 2018 Aug.
Article en En | MEDLINE | ID: mdl-28728449
In this effort, we provided comparative study on optimization of transfection conditions for AGS human gastric cancer cell line using two commercial non-liposomal cationic lipids. Using reporter vector pEGFP-N1, transfection efficiency of Attractene™ and X-tremeGENE HP™ transfection reagents in terms of cell densities and DNA/reagent ratios was determined in AGS cells by flow cytometry and fluorescence microscopy. In addition, influence of transfection reagents on direct cytotoxicity and cell viability was respectively, measured using lactate dehydrogenase (LDH) leakage and MTT assays. Provided that the transfection rate of 29% and the mean fluorescence intensity of 437.5, the DNA/reagent ratio of 0.4/1.5 was selected as the optimal condition using Attractene™, whereas the optimum condition using X-tremeGENE HP™ was obtained by the ratio of 1/2 with a higher transfection rate of 36.9% and an MFI of 833. Very low direct cytotoxicity (<5% and 6-9% using Attractene™ and X-tremeGENE HP™, respectively) and high cell viability (74.5-95.5% versus 68-75%) showed the biodegradable attribute for both transfection reagents. Altogether, X-tremeGENE HP™ exhibited superiority over Attractene™ as a transfection reagent for AGS cells. In the present research, we have established the optimized protocols for efficient transfection of AGS cells with potential applications in gene function and expression studies as well as gene therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Portadores de Fármacos / Transfección / Lípidos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Artif Cells Nanomed Biotechnol Año: 2018 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Portadores de Fármacos / Transfección / Lípidos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Artif Cells Nanomed Biotechnol Año: 2018 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido